Langerhans cell histiocytosis · 6 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Cytarabine and Methotrexate (CYM) Variant #03 | — | R 5 979 | 21d | — | — | — | — | — |
Etoposide, Vinblastine, Prednisone Variant #01 | — | R 5 813 | 42d | — | — | — | — | — |
Etoposide and Methylprednisolone Variant #01 | — | R 4 450 | 21d | — | — | — | — | — |
Vinblastine and Methylprednisolone Variant #01 | — | R 3 176 | 7d | — | — | — | — | — |
Vinblastine and Prednisone Variant #01 | — | R 2 151 | 42d | — | — | — | — | — |
Methotrexate, Vinblastine, Prednisone Variant #01 | — | R 1 895 | 42d | — | — | — | — | — |
6 of 6 regimens shown